Q1 2025 Treace Medical Concepts Inc Earnings Call Transcript
Key Points
- Treace Medical Concepts Inc (TMCI) reported a revenue of $52.6 million for Q1 2025, marking a 3% growth over the same period in 2024, and a 4.5% growth when adjusted for one less selling day.
- The company has successfully expanded its portfolio with three new bunion correction systems, which are expected to target 100% of surgeon and patient preferences for bunion correction.
- Treace Medical Concepts Inc (TMCI) has received positive feedback from surgeons on its new systems and training programs, indicating strong market interest and potential for growth.
- The company has improved its adjusted EBITDA loss by 54% compared to the first quarter of 2024, marking the third consecutive quarter of improvements.
- Treace Medical Concepts Inc (TMCI) maintains a strong balance sheet with $76.1 million in cash, cash equivalents, and marketable securities, and access to an additional $22.5 million through an existing revolver.
- Gross margin decreased slightly to 79.7% in Q1 2025 from 80.2% in Q1 2024.
- The company reported a net loss of $15.9 million or $0.25 per share for the first quarter of 2025, although this is an improvement from the previous year.
- Revenue growth for Q2 2025 is expected to be consistent with Q2 2024, indicating a slower growth rate in the first half of the year.
- There is uncertainty regarding the impact of the step-up in hospital outpatient ASC reimbursement on the company's performance.
- The company faces competition from other companies offering Lapiplasty knockoffs, although it believes its products remain superior.
Good day, and thank you for standing by. Welcome to the Treace Medical Concepts first-quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference call is being recorded.
I would now like to hand the conference over to your first speaker today, Trip Taylor, Investor Relations. Please go ahead.
Thank you. (technical difficulty) Thank you, operator. Good afternoon, everyone, and welcome to our first quarter 2025 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer. During the call, John will offer commentary on our commercial activities, followed by Mark for a review of our first quarter financial results released after market close today.
We will then host a question-and-answer session following our prepared remarks. Our press release can be found in the Investor Relations section of our website at investors.treace.com. This call is being recorded and will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
